A high red blood cell distribution width predicts failure of arteriovenous fistula

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Bojakowski, Krzysztof ^a   Dzabic, Mensur ^b   Kurzejamska, Ewa ^b   Styczynski, Grzegorz ^a   Andziak, Piotr ^a   Gaciong, Zbigniew ^a   Söderberg Nauclér, Cecilia ^b   Religa, Piotr ^b  

^a UNIVERSITY OF WARSAW   (Poland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD68 ANTIGEN; BIOLOGICAL MARKER;

ARTICLE; BLOOD VESSEL BIOPSY; CHEMICAL PARAMETERS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ERYTHROCYTE PARAMETERS; FEMALE; HAZARD RATIO; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; NATIVE ARTERIOVENOUS FISTULA; NATIVE ARTERIOVENOUS FISTULA DYSFUNCTION; NATIVE ARTERIOVENOUS FISTULA FAILURE; OBSERVATIONAL STUDY; POLAND; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RED BLOOD CELL DISTRIBUTION WIDTH; RISK FACTOR; SURGICAL WARD; VASCULAR ACCESS; VASCULAR DISEASE; VASCULAR PATENCY; AGED; ARTERIOVENOUS FISTULA; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CYTOLOGY; ERYTHROCYTE COUNT; METABOLISM; METHODOLOGY; MIDDLE AGED; RADIAL ARTERY; RENAL REPLACEMENT THERAPY; TIME; TREATMENT FAILURE; VEIN;

FISTULA;

AGED; ARTERIOVENOUS FISTULA; BIOLOGICAL MARKERS; COHORT STUDIES; ERYTHROCYTE COUNT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; RADIAL ARTERY; RENAL DIALYSIS; RISK FACTORS; TIME FACTORS; TREATMENT FAILURE; VEINS;

EID: 84860540540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036482     Document Type: Article

References (32)

1. Eknoyan G, Levin NW, Steinberg E, (1997) The National Kidney Foundation Dialysis Outcomes Quality Initiative. Curr Opin Nephrol Hypertens 6: 520-523.
2. Feldman HI, Kobrin S, Wasserstein A, (1996) Hemodialysis vascular access morbidity. J Am Soc Nephrol 7: 523-535.
3. Allon M, Robbin ML, (2002) Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 62: 1109-1124.
4. Roy-Chaudhury P, Sukhatme VP, Cheung AK, (2006) Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112-1127.
5. Huber TS, Carter JW, Carter RL, Seeger JM, (2003) Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 38: 1005-1011.
6. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, et al. (2010) Hyperglycaemia, a prothrombotic factor? J Thromb Haemost.
7. Grant PJ, (2007) Diabetes mellitus as a prothrombotic condition. J Intern Med 262: 157-172.
8. Lin CC, Yang WC, (2009) Prognostic factors influencing the patency of hemodialysis vascular access: literature review and novel therapeutic modality by far infrared therapy. J Chin Med Assoc 72: 109-116.
9. Grandaliano G, Teutonico A, Allegretti A, Losappio R, Mancini A, et al. (2003) The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int 64: 715-719.
10. Gagliardi GM, Rossi S, Condino F, Mancuso D, Greco F, et al. (2011) Malnutrition, infection and arteriovenous fistula failure: is there a link? J Vasc Access 12: 57-62.
11. Dzabic M, Bojakowski K, Kurzejamska E, Styczynski G, Andziak P, et al. (2012) Significance of cytomegalovirus infection in the failure of native arteriovenous fistula. Clin Microbiol Infect 18: E5-7.
12. Casserly LF, Dember LM, (2003) Thrombosis in end-stage renal disease. Semin Dial 16: 245-256.
13. Chou CY, Kuo HL, Yung YF, Liu YL, Huang CC, (2006) C-reactive protein predicts vascular access thrombosis in hemodialysis patients. Blood Purif 24: 342-346.
14. De Marchi S, Falleti E, Giacomello R, Stel G, Cecchin E, et al. (1996) Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 7: 1169-1177.
15. Durante W, Lin CC, (2008) HOming in on arteriovenous fistula survival. Kidney Int 74: 9-11.
16. Wali MA, Eid RA, Dewan M, Al-Homrany MA, (2003) Intimal changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction. J Smooth Muscle Res 39: 95-105.
17. Chang CJ, Ko YS, Ko PJ, Hsu LA, Chen CF, et al. (2005) Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 68: 1312-1319.
18. Evans TC, Jehle D, (1991) The red blood cell distribution width. J Emerg Med 9 (Suppl 1): 71-74.
19. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, et al. (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50: 40-47.
20. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, et al. (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158: 659-666.
21. van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, et al. (2010) Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 12: 129-136.
22. Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, et al. (2010) Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141: 141-146.
23. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ, (2009) Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 104: 868-872.
24. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, et al. (2008) Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 117: 163-168.
25. Ani C, Ovbiagele B, (2009) Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci 277: 103-108.
26. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, et al. (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133: 628-632.
27. Lappe JM, Horne BD, Shah SH, May HT, Muhlestein JB, et al. (2011) Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta 412: 2094-2099.
28. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, et al. (1991) Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 260: H1713-1717.
29. Wang Z, Newman WH, (2003) Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization. J Surg Res 111: 261-266.
30. Baron M, Hudson M, Steele R, (2010) Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm. J Am Coll Nutr 29: 144-151.
31. Andrews DA, Low PS, (1999) Role of red blood cells in thrombosis. Curr Opin Hematol 6: 76-82.
32. Barshtein G, Ben-Ami R, Yedgar S, (2007) Role of red blood cell flow behavior in hemodynamics and hemostasis. Expert Rev Cardiovasc Ther 5: 743-752.